Medtide expects H1 profit to fall 44%-52% to RMB 49.4 million-RMB 57.1 million

• Flagged weaker 1H 2026 results: revenue RMB 229.8 million–RMB 239.2 million, down 5.7%–9.4% from RMB 253.8 million.
• Profit seen at RMB 49.4 million–RMB 57.1 million, down 44%–51.6% from RMB 102 million.
• Adjusted net profit forecast at RMB 51.4 million–RMB 59.3 million, down 43.1%–50.6% from RMB 104.1 million.
• Cited delayed order deliveries into 2H 2026, RMB appreciation driving FX losses, lower gross profit, no repeat of 1H 2025 FVTPL gain.
• Noted a significant overseas customer order secured in July 2026, strengthening backlog.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260731-12263559), on July 31, 2026, and is solely responsible for the information contained therein.